Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion

AIM: To determine the 2-year outcomes of intravitreal bevacizumab (IVB) injections in eyes with macular oedema (ME) following branch retinal vein occlusion (BRVO). METHODS: Of 105 consecutive eyes (105 treatment-naïve patients) with ME following BRVO, 89 eyes were followed for 2 years after the firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hikichi, Taiichi, Higuchi, Makoto, Matsushita, Takuro, Kosaka, Shoko, Matsushita, Reiko, Takami, Kimitaka, Ohtsuka, Hideo, Kitamei, Hirokuni, Shioya, Shoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913112/
https://www.ncbi.nlm.nih.gov/pubmed/24215032
http://dx.doi.org/10.1136/bjophthalmol-2013-303121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913112/
https://www.ncbi.nlm.nih.gov/pubmed/24215032
http://dx.doi.org/10.1136/bjophthalmol-2013-303121

Ejemplares similares